{"id":"W2088416509","doi":"10.1158/1538-7445.am2014-ct404","title":"Abstract CT404: Phase I/II study of VAL-083 in patients with recurrent glioblastoma multiforme","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Tolerability; Bevacizumab; Oncology; Clinical trial; Phases of clinical research; Internal medicine; Cancer; Radiation therapy; Brain tumor; Chemotherapy; Cancer research; Pathology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009414008,0.001782163,0.001964268,0.000606865,0.0004446666,0.0007883999,0.001016543,0.001008072,0.003584349],"category_scores_gemma":[0.0004439805,0.0005960614,0.001090999,0.0006161336,0.0007799092,0.0004925217,0.0003173191,0.00240673,0.001145813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001285942,"about_ca_system_score_gemma":0.002185942,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003436181,"about_ca_topic_score_gemma":0.006560771,"domain_scores_codex":[0.9997236,0.000127845,0.00001378033,0.00003970486,0.00003296577,0.00006193428],"domain_scores_gemma":[0.9996837,0.00002991695,0.00004615131,0.00002800733,0.00003117422,0.0001809553],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5195811,0.09852695,0.01818656,0.001321829,0.002323932,0.0008961837,0.0006359259,0.006982552,0.176776,0.0007351759,0.01343128,0.1606025],"study_design_scores_gemma":[0.2461216,0.7084164,0.02556055,0.00006493066,0.0005890874,0.0007164091,0.0001347576,0.002211972,0.01045037,0.0002925901,0.005382759,0.00005856198],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943261,0.00121948,0.0003008787,0.0003485345,0.0000763217,0.001164761,0.001112606,0.0001595731,0.001291738],"genre_scores_gemma":[0.9885506,0.001528195,0.001114213,0.0006230237,0.00009486618,0.001438454,0.003594586,0.00004230396,0.003013802],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003584349,"threshold_uncertainty_score":0.01199085,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05514589239297792,"score_gpt":0.4188260267205755,"score_spread":0.3636801343275976,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}